The company registered net profit after other income of Rs 13.5 crore
The Board of Novartis India approved the results for the quarter ended June 30, 2015. During the period under review, total income from operations was Rs 224.1 crore as compared to Rs 208.8 crore during the corresponding quarter of the previous year.
During the quarter under review, pharmaceuticals recorded total income from operations of Rs 168.9 crore as against Rs 150.6 crore in the previous corresponding quarter. The generics business registered total income from operations of Rs 11.2 crore as against Rs 12.3 crore in the previous corresponding period. The animal health business registered total income from operations of Rs 24.5 crore as against Rs 23 crore in the previous corresponding period. The OTC business recorded total income from operations of Rs 19.5 crore as against Rs 22.8 crore in the previous corresponding quarter.
During the quarter under review the company recorded a profit from operations of Rs 0.4 crore as compared to loss from operations of Rs 4 crore during the corresponding quarter of the previous year. The company registered net profit after other income of Rs 13.5 crore as against Rs 14.3 crore in the previous corresponding period.
- Advertisement -
Comments are closed.